Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 172

Results For "Medica"

2469 News Found

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency
Biotech | April 23, 2022

NovoSeven recommended for approval for the treatment of severe postpartum haemorrhage by the European Medicines Agency

Heavy bleeding after giving birth is globally a leading cause of death in new mothers


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic


Terran Biosciences announces licensing deal with Sanofi
Biotech | April 22, 2022

Terran Biosciences announces licensing deal with Sanofi

Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics


First ever nationwide epidemiological diabetes study released
Healthcare | April 22, 2022

First ever nationwide epidemiological diabetes study released

Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications


ZEISS announces USFDA clearance of the Quatera 700
Digitisation | April 21, 2022

ZEISS announces USFDA clearance of the Quatera 700

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise


BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
Drug Approval | April 20, 2022

BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer

The launch is yet another first of its kind innovation in India


India Health Link join hands with U GRO Capital
Healthcare | April 20, 2022

India Health Link join hands with U GRO Capital

U GRO Capital is a listed MSME lending fintech platform